<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Public Health</journal-id><journal-id journal-id-type="iso-abbrev">Front Public Health</journal-id><journal-id journal-id-type="publisher-id">Front. Public Health</journal-id><journal-title-group><journal-title>Frontiers in Public Health</journal-title></journal-title-group><issn pub-type="epub">2296-2565</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12098052</article-id><article-id pub-id-type="doi">10.3389/fpubh.2025.1564206</article-id><article-categories><subj-group subj-group-type="heading"><subject>Public Health</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Cross-sectional association between hs-CRP/HDL-C ratio and physical frailty among middle-aged and older adults: findings from a population-based study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yina</given-names></name><uri xlink:href="https://loop.frontiersin.org/people/2220498/overview"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Su</surname><given-names>Jing</given-names></name><uri xlink:href="https://loop.frontiersin.org/people/3042830/overview"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Yang</given-names></name><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1808664/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff><institution>Department of Geriatrics, The Second Xiangya Hospital of Central South University</institution>, <addr-line>Changsha, Hunan</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by" id="fn0001"><p>Edited by: Alexey Moskalev, Komi Scientific Center (RAS), Russia</p></fn><fn fn-type="edited-by" id="fn0002"><p>Reviewed by: Sylwia Dziegielewska-Gesiak, Medical University of Silesia, Poland</p><p>Lorenzo Blandi, University of Pavia, Italy</p></fn><corresp id="c001">*Correspondence: Yang Wang, <email>1913654513@qq.com</email></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>13</volume><elocation-id>1564206</elocation-id><history><date date-type="received"><day>21</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>14</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Wang, Su and Wang.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Wang, Su and Wang</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec id="sec1"><title>Background</title><p>Frailty, characterized by functional decline and disability, is an emerging public health concern in aging populations. Chronic inflammation and low high-density lipoprotein cholesterol (HDL-C) levels are key contributors to the progression of frailty. This study aims to examine the association between the ratio of high-sensitivity C-reactive protein (hs-CRP) to HDL-C and frailty among middle-aged and older adults in the United States.</p></sec><sec id="sec2"><title>Methods</title><p>Our study included participants aged 45&#x0202f;years and older from the 2015&#x02013;2020 National Health and Nutrition Examination Survey (NHANES). Logistic regression and restricted cubic spline (RCS) analysis were utilized to assess the relationship between the hs-CRP/HDL-C ratio and frailty, adjusting for potential confounding covariates. Mediation analysis was performed to determine whether plasma proteins mediated this association. Least absolute shrinkage and selection operator (LASSO) regression was employed to identify variables strongly correlated with frailty, and a nomogram was subsequently developed based on these variables.</p></sec><sec id="sec3"><title>Results</title><p>Our study included 3,626 middle-aged and older participants, among whom 787(21.7%) were identified as frailty. After adjusting for all covariates, a high hs-CRP/HDL-C ratio was identified as a significant risk factor for frailty (OR&#x0202f;=&#x0202f;1.736, 95% CI: 1.009&#x02013;2.988). RCS analysis disclosed a nonlinear correlation between the hs-CRP/HDL-C ratio and frailty incidence. Furthermore, mediation analysis suggested that albumin and globulin partially mediated this association, accounting for 37.82% and 11.23% of the indirect effect, respectively. A nomogram, constructed using variables selected via LASSO regression, exhibited promising discriminative ability, with an area under the curve (AUC) of 79.7% (95% CI: 77.7&#x02013;81.75%).</p></sec><sec id="sec4"><title>Conclusion</title><p>Our findings suggest that a higher hs-CRP/HDL-C ratio is associated with an increased risk of frailty among middle-aged and older adults. Albumin and globulin partially mediate this relationship. Additionally, the nomogram developed in our study shows strong predictive ability for identifying individuals at high risk of frailty in this population.</p></sec></abstract><kwd-group><kwd>frailty</kwd><kwd>hs-CRP</kwd><kwd>HDL-C</kwd><kwd>NHANES</kwd><kwd>plasma proteins</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the National Natural Scientific Foundation (81100059), the Natural Scientific Fund of Hunan province (2020JJ4812,2021JJ31013,2023JJ30786,2025JJ50713, 2025JJ60578), Health and Health Project of Hunan Provincial Department of Finance (Xiang Cai She Zhi [2023] No. 79,Xiang Cai She Zhi [2024] No.0031), and Degree &#x00026; Postgraduate Education Reform Project of Central South University(2022JGB075, 2023YJSKS035), China. The funding source had no role in the design, methods, subject recruitment, data collections, analysis, and preparation of this paper.</funding-statement></funding-group><counts><fig-count count="6"/><table-count count="3"/><equation-count count="0"/><ref-count count="48"/><page-count count="11"/><word-count count="6335"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Aging and Public Health</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec5"><label>1</label><title>Introduction</title><p>The global aging population is growing rapidly (<xref rid="ref1" ref-type="bibr">1</xref>). Frailty, an age-associated clinical syndrome, serves as an important indicator for identifying individuals at high risk of adverse outcomes, including falls, hospitalization, disability, and mortality (<xref rid="ref2" ref-type="bibr">2</xref>, <xref rid="ref3" ref-type="bibr">3</xref>). It is a multifactorial condition influenced by various biological mechanisms such as chronic inflammation, oxidative stress, nutritional status(e.g., albumin and diet), aging, and physical activity (<xref rid="ref4" ref-type="bibr">4</xref>). The frailty index (FI) is a widely accepted tool for assessing frailty across populations (<xref rid="ref5" ref-type="bibr">5</xref>). Given the wide range of complications associated with frailty, it is crucial to identify reliable biomarkers to predict and slow the progression of frailty.</p><p>Inflammation plays a crucial role in the development of frailty (<xref rid="ref6" ref-type="bibr">6</xref>, <xref rid="ref7" ref-type="bibr">7</xref>). C-reactive protein (CRP), a well-established marker of inflammation, has been linked to reduced muscle mass and strength (<xref rid="ref8" ref-type="bibr">8</xref>). However, the relationship between CRP and frailty remains inconclusive. In an observational study by Kamil R. J. et al., no significant association was found between CRP levels and frailty risk (<xref rid="ref9" ref-type="bibr">9</xref>). Conversely, Luo et al. reported elevated CRP levels among individuals with frailty (<xref rid="ref10" ref-type="bibr">10</xref>). High-sensitivity CRP (hs-CRP) assays, commonly used in clinical practice, enable precise detection of CRP levels and serve as valuable predictors of cardiovascular disease and stroke (<xref rid="ref11" ref-type="bibr">11</xref>, <xref rid="ref12" ref-type="bibr">12</xref>). In addition to inflammatory markers, lipid metabolism also plays a role in frailty. Reduced high-density lipoprotein cholesterol (HDL-C) levels are frequently observed in individuals with chronic conditions (<xref rid="ref13" ref-type="bibr">13</xref>). HDL-C, known for its anti-inflammatory properties, has been inversely associated with frailty in older adults (<xref rid="ref14" ref-type="bibr">14</xref>, <xref rid="ref15" ref-type="bibr">15</xref>). Both hs-CRP and HDL-C are common biomarkers for assessing inflammation and lipid status in clinical settings. Previous research has established that the hs-CRP/HDL-C ratio may serve as a risk indicator for new stroke and cardiovascular issues (<xref rid="ref16" ref-type="bibr">16</xref>). However, few studies have examined the relationship between the hs-CRP/HDL-C ratio and frailty in large, population-based cohorts. Our research aims to explore whether the hs-CRP/HDL-C ratio can serve as a useful biomarker for identifying frailty among middle-aged and older adult individuals. To achieve this, we will analyze extensive data from the National Health and Nutrition Examination Survey (NHANES) spanning from 2015 to 2020. This study presents an opportunity to identify a more reliable biomarker for frailty assessment in middle-aged and older populations.</p></sec><sec sec-type="methods" id="sec6"><label>2</label><title>Methods</title><sec id="sec7"><label>2.1</label><title>Data collection and study population</title><p>The data for this study were obtained from the 2015&#x02013;2020&#x0202f;cycles of the NHANES, a publicly available cross-sectional survey designed to evaluate the health and nutritional status of the U.S. population. Because of the COVID-19 pandemic, data obtained from 2019 to March 2020 were combined with data from the 2017&#x02013;2018&#x0202f;cycle to form a nationally representative pre-pandemic dataset covering the period from 2017 to March 2020. A total of 3,626 participants aged 45&#x0202f;years and older were included in the final analysis. Individuals with incomplete data required to construct the frailty index, or with missing data for hs-CRP, HDL-C, or other selected covariates, were excluded. The final cohort is representative of approximately 7.05 million non-institutionalized residents of the U.S. A flowchart detailing participant recruitment is provided in <xref rid="fig1" ref-type="fig">Figure 1</xref>.</p><fig position="float" id="fig1"><label>Figure 1</label><caption><p>The participant screening flowchart.</p></caption><graphic xlink:href="fpubh-13-1564206-g001" position="float"/></fig></sec><sec id="sec8"><label>2.2</label><title>The hs-CRP/HDL-C ratio</title><p>During all three cycles of the NHANES, serum samples were obtained for analysis. Serum levels of hs-CRP (mg/L) and HDL-C (mg/dL) were analyzed at the University of Minnesota, Minneapolis, MN. The hs-CRP/HDL-C ratio was determined by dividing the concentration of hs-CRP by the concentration of HDL-C. The hs-CRP/HDL-C ratio was categorized into quartiles (Q1&#x02013;Q4) based on its distribution.</p></sec><sec id="sec9"><label>2.3</label><title>Frailty index</title><p>Frailty was evaluated using the frailty index (FI), constructed from 49 health deficits as presented in <xref rid="SM1" ref-type="supplementary-material">Supplementary Table S1</xref> (<xref rid="ref17" ref-type="bibr">17</xref>, <xref rid="ref18" ref-type="bibr">18</xref>). The health deficits encompassed various aspects such as cognition, dependency, depressive symptoms, comorbidities, hospital utilization and access to care, physical performance, and laboratory values. The FI was computed by dividing the total number of deficits identified in each participant by the overall number of deficits considered. This index yields a score ranging from 0 to 1, with a higher score indicating a higher number of deficits and a frailer condition. In accordance with previous research (<xref rid="ref19" ref-type="bibr">19</xref>, <xref rid="ref20" ref-type="bibr">20</xref>), frailty status was categorized based on the FI score: an FI score of &#x0003c;0.25 denoting non-frailty, and an FI score of &#x02265;0.25 denoting frailty.</p></sec><sec id="sec10"><label>2.4</label><title>Covariates</title><p>Multiple sociodemographic factors including age, gender (male, female), marital status (non-single and single), ethnicity (Non-Hispanic White, Non-Hispanic Black, Mexican American, and Other Race), and educational level (&#x0003e; High school, High school, &#x0003c;High school) were collected as covariates. Additionally, the family income-to-poverty ratio (FITPR) was classified as &#x0003c; 1.3, 1.3&#x02013;3.5, and &#x0003e; 3.5 based on the household income to poverty guidelines ratio (<xref rid="ref21" ref-type="bibr">21</xref>). Lifestyle factors such as physical activity and smoking status were included. Physical activity was assessed using metabolic equivalent minutes per week, calculated by multiplying the total time spent in transportation, work, and recreational activity. Physical activity was categorized as &#x0003c;500 and &#x02265;500 metabolic equivalent minutes per week, based on the World Health Organization&#x02019;s recommended physical activity level (<xref rid="ref22" ref-type="bibr">22</xref>). Smoking status was classified into two categories: &#x0201c;no&#x0201d; (individuals who smoked fewer than 100 cigarettes in their lifetime, or previously smoked more than 100 cigarettes but quit and are currently nonsmokers) and &#x0201c;yes&#x0201d; (individuals who smoked more than 100 cigarettes in their lifetime and are currently smokers) (<xref rid="ref23" ref-type="bibr">23</xref>).</p><p>For energy intake, a 2-day dietary value obtained from Day 1 and Day 2 or using data from Day 1 when Day 2 data were missing. Alcohol consumption was categorized into five groups: former drinkers, nondrinkers, mild drinkers, moderate drinkers, heavy drinkers, as indicated in previous studies (<xref rid="ref24" ref-type="bibr">24</xref>). Medical condition data encompassed BMI (weight in kg divided by height in meters squared), serum creatinine concentration measured in mg/dL using the Jaffe rate method, and various health statuses. Diabetes mellitus status was classified into four categories: Diabetes mellitus (DM, defined as fasting glucose &#x02265; 7.0&#x0202f;mmol/L, random plasma glucose &#x02265; 11.1&#x0202f;mmol/L, two-hour OGTT blood glucose &#x02265; 11.1&#x0202f;mmoL/L; glycohemoglobin HbA1c&#x0202f;&#x02265;&#x0202f;6.5%, self-reported physician-diagnosed diabetes, or current use of antidiabetic drugs), pre-DM (fasting glucose level should be between 6.11&#x0202f;mmol/L and 7.0&#x0202f;mmol/L, or two-hour OGTT blood glucose range from 7.7&#x0202f;mmol/L to less than 11.1&#x0202f;mmol/L), or &#x02018;no&#x02019; (normal glucose levels). Hypertension status was determined as &#x02018;yes&#x02019; for elevated blood pressure or medication use, and &#x02018;no&#x02019; for normal blood pressure. Similarly, stroke status was classified as either &#x0201c;yes&#x0201d; or &#x0201c;no&#x0201d; based on participants&#x02019; self-reported history of physician-diagnosed stroke.</p></sec><sec id="sec11"><label>2.5</label><title>Statistical analysis</title><p>Data analysis was conducted using R software version 4.4.0, incorporating the nhanesR (0.9.5.0), ggplot2, rms, and mediation packages (<xref rid="ref23" ref-type="bibr">23</xref>). In alignment with analytic guidelines, sample weights were incorporated to ensure the national representativeness of the survey. Baseline characteristics of participants were stratified by frailty status, with survey-weighted mean &#x000b1; standard error [SE] for continuous variables and survey-weighted proportions for categorical variables. Group comparisons were conducted utilizing survey-weighted t-test for continuous variables and survey-weighted Rao-Scott chi-square test for categorical variables. The association between the hs-CRP/HDL-C ratio and frailty status was examined through univariate and multivariate logistic regression models. Covariates were selected based on prior literature and clinical relevance. The crude model was unadjusted for any covariates. Model I adjusted for age, gender, ethnicity, and education status. Model II further included age, gender, marital status, ethnicity, education status, BMI, energy intake, FITPR, physical activity, smoking status, alcohol user status, creatinine levels, and comorbidities (hypertension, DM, and stroke). Results of the logistic regression were presented as odds ratios (ORs) with 95% confidence intervals (CIs). Restricted cubic splines (RCS) regression were used to evaluate potential non-linear relationships between the hs-CRP/HDL-C ratio and FI score. Additionally, multivariable linear regression was used to explore the associations between the hs-CRP/HDL-C ratio and plasma proteins (albumin and globulin). Causal mediation analysis was conducted to investigate if the association between the hs-CRP/HDL-C ratio and frailty status was mediated by plasma proteins. The mediation effect was estimated using bootstrapping with 1,000 resamples, and indirect, direct, and total effects were reported.</p><p>To develop and validate a predictive nomogram, the dataset was randomly divided into a training set (70% of the data) and a validation set (30% of the data), stratified by frailty status. Least absolute shrinkage and selection operator (LASSO) regression, implemented using the glmnet package, was applied to identify the key predictors in the training set. The largest penalty parameter lambda (<italic>&#x003bb;</italic>) within one standard error of the minimum binomial deviation, was selected based on tenfold cross-validation with 1,000 iterations. Variables with non-zero coefficients were retained for the final model. A nomogram was then constructed using multivariate logistic regression, and its discriminatory performance was evaluated using the receiver operating characteristic (ROC) curve. Statistical significance was defined as a two-sided <italic>p</italic> value of less than 0.05.</p></sec></sec><sec sec-type="results" id="sec12"><label>3</label><title>Results</title><sec id="sec13"><label>3.1</label><title>Baseline characteristics</title><p>Baseline characteristics stratified by frailty status are presented in <xref rid="tab1" ref-type="table">Table 1</xref>. The study comprised 3,626 participants (2,839 non-frailty and 787 frailty), comprising 1935 males and 1,691 females, with a mean age of 59.67&#x0202f;&#x000b1;&#x0202f;0.34&#x0202f;years. The frailty group had a significantly higher mean age (63.59&#x0202f;&#x000b1;&#x0202f;0.55&#x0202f;years) compared to the non-frailty group (58.97&#x0202f;&#x000b1;&#x0202f;0.36&#x0202f;years, <italic>p</italic> &#x0003c;&#x0202f;0.0001). Additionally, the proportion of older individuals (&#x02265;75&#x0202f;years) was significantly higher in the frail group (17.07%) compared to the non-frail group (7.58%). Notably, the frailty group displayed higher values in hs-CRP/HDL-C ratios, creatinine levels, and a greater incidence of single status, diabetes mellitus(DM), hypertension, and stroke than the non-frailty group. Moreover, the frailty group displayed less values in energy intake than the non-frailty group. Significant intergroup differences were identified across a range of variables, including age, marital status, ethnicity, education level, BMI, energy intake, FITPR, physical activity, creatinine levels, smoking status, alcohol consumption, hs-CRP/HDL-C ratio, diabetes mellitus status, hypertension status, and stroke status, as delineated in <xref rid="tab1" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="tab1"><label>Table 1</label><caption><p>Baseline characteristics of participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Variables</th><th align="center" valign="top" rowspan="1" colspan="1">Total</th><th align="center" valign="top" rowspan="1" colspan="1">Non-frailty</th><th align="center" valign="top" rowspan="1" colspan="1">Frailty</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>n</italic> (sample size)</td><td align="center" valign="bottom" rowspan="1" colspan="1">3,626</td><td align="center" valign="bottom" rowspan="1" colspan="1">2,839</td><td align="center" valign="bottom" rowspan="1" colspan="1">787</td><td rowspan="2" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>N</italic> (weighted- sample size)</td><td align="center" valign="bottom" rowspan="1" colspan="1">70,478,619</td><td align="center" valign="bottom" rowspan="1" colspan="1">59,879,934</td><td align="center" valign="bottom" rowspan="1" colspan="1">10,598,685</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="bottom" rowspan="1" colspan="1">59.67&#x0202f;&#x000b1;&#x0202f;0.34</td><td align="center" valign="bottom" rowspan="1" colspan="1">58.97&#x0202f;&#x000b1;&#x0202f;0.36</td><td align="center" valign="bottom" rowspan="1" colspan="1">63.59&#x0202f;&#x000b1;&#x0202f;0.55</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Age (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">45&#x02013;60&#x0202f;years</td><td align="center" valign="bottom" rowspan="1" colspan="1">1729 (53.66)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,445 (56.38)</td><td align="center" valign="bottom" rowspan="1" colspan="1">284 (38.33)</td><td rowspan="3" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">60&#x02013;75&#x0202f;years</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,471 (37.33)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,113 (36.04)</td><td align="center" valign="bottom" rowspan="1" colspan="1">358 (44.60)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">&#x02265;75&#x0202f;years</td><td align="center" valign="bottom" rowspan="1" colspan="1">426 (9.01)</td><td align="center" valign="bottom" rowspan="1" colspan="1">281 (7.58)</td><td align="center" valign="bottom" rowspan="1" colspan="1">145 (17.07)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Gender (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Female</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,691 (49.62)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,304 (48.69)</td><td align="center" valign="bottom" rowspan="1" colspan="1">387 (54.87)</td><td rowspan="2" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Male</td><td align="center" valign="bottom" rowspan="1" colspan="1">1935 (50.38)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,535 (51.31)</td><td align="center" valign="bottom" rowspan="1" colspan="1">400 (45.13)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Marital Status (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Non-single</td><td align="center" valign="bottom" rowspan="1" colspan="1">2,293 (71.79)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1893 (74.23)</td><td align="center" valign="bottom" rowspan="1" colspan="1">400 (58.01)</td><td rowspan="2" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Single</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,333 (28.21)</td><td align="center" valign="bottom" rowspan="1" colspan="1">946 (25.77)</td><td align="center" valign="bottom" rowspan="1" colspan="1">387 (41.99)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Ethnicity (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Non-Hispanic White</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,512 (75.12)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,190 (76.69)</td><td align="center" valign="bottom" rowspan="1" colspan="1">322 (66.22)</td><td rowspan="4" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Non-Hispanic Black</td><td align="center" valign="bottom" rowspan="1" colspan="1">807 (8.27)</td><td align="center" valign="bottom" rowspan="1" colspan="1">590 (7.33)</td><td align="center" valign="bottom" rowspan="1" colspan="1">217 (13.58)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Mexican American</td><td align="center" valign="bottom" rowspan="1" colspan="1">424 (4.98)</td><td align="center" valign="bottom" rowspan="1" colspan="1">350 (5.07)</td><td align="center" valign="bottom" rowspan="1" colspan="1">74 (4.44)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Other Race</td><td align="center" valign="bottom" rowspan="1" colspan="1">883 (11.64)</td><td align="center" valign="bottom" rowspan="1" colspan="1">709 (10.91)</td><td align="center" valign="bottom" rowspan="1" colspan="1">174 (15.76)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Education (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">&#x0003c;High school</td><td align="center" valign="bottom" rowspan="1" colspan="1">606 (8.40)</td><td align="center" valign="bottom" rowspan="1" colspan="1">429 (7.20)</td><td align="center" valign="bottom" rowspan="1" colspan="1">177 (15.20)</td><td rowspan="3" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">High school</td><td align="center" valign="bottom" rowspan="1" colspan="1">826 (23.08)</td><td align="center" valign="bottom" rowspan="1" colspan="1">609 (21.52)</td><td align="center" valign="bottom" rowspan="1" colspan="1">217 (31.89)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">&#x0003e;High school</td><td align="center" valign="bottom" rowspan="1" colspan="1">2,194 (68.51)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1801 (71.28)</td><td align="center" valign="bottom" rowspan="1" colspan="1">393 (52.91)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">BMI (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">&#x0003c;25</td><td align="center" valign="bottom" rowspan="1" colspan="1">827 (24.15)</td><td align="center" valign="bottom" rowspan="1" colspan="1">718 (26.12)</td><td align="center" valign="bottom" rowspan="1" colspan="1">109 (13.05)</td><td rowspan="3" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">25&#x02013;30</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,282 (35.95)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,032 (36.64)</td><td align="center" valign="bottom" rowspan="1" colspan="1">250 (32.06)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">&#x02265; 30</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,517 (39.90)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,089 (37.24)</td><td align="center" valign="bottom" rowspan="1" colspan="1">428 (54.89)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Energy intake (kcal)</td><td align="center" valign="bottom" rowspan="1" colspan="1">2135.93&#x0202f;&#x000b1;&#x0202f;17.53</td><td align="center" valign="bottom" rowspan="1" colspan="1">2162.94&#x0202f;&#x000b1;&#x0202f;18.92</td><td align="center" valign="bottom" rowspan="1" colspan="1">1983.34&#x0202f;&#x000b1;&#x0202f;41.45</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">FITPR (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">&#x0003c;1.5</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,013 (15.00)</td><td align="center" valign="bottom" rowspan="1" colspan="1">673 (11.76)</td><td align="center" valign="bottom" rowspan="1" colspan="1">340 (33.28)</td><td rowspan="3" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">1.5&#x02013;3.37</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,116 (25.87)</td><td align="center" valign="bottom" rowspan="1" colspan="1">867 (24.70)</td><td align="center" valign="bottom" rowspan="1" colspan="1">249 (32.52)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">&#x0003e;3.37</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,497 (59.13)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,299 (63.54)</td><td align="center" valign="bottom" rowspan="1" colspan="1">198 (34.20)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Physical activity (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">&#x0003c;500</td><td align="center" valign="bottom" rowspan="1" colspan="1">674 (17.14)</td><td align="center" valign="bottom" rowspan="1" colspan="1">499 (16.28)</td><td align="center" valign="bottom" rowspan="1" colspan="1">175 (21.99)</td><td rowspan="2" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">&#x02265;500</td><td align="center" valign="bottom" rowspan="1" colspan="1">2,952 (82.86)</td><td align="center" valign="bottom" rowspan="1" colspan="1">2,340 (83.72)</td><td align="center" valign="bottom" rowspan="1" colspan="1">612 (78.01)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Smoke (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Yes</td><td align="center" valign="bottom" rowspan="1" colspan="1">619 (14.64)</td><td align="center" valign="bottom" rowspan="1" colspan="1">430 (12.88)</td><td align="center" valign="bottom" rowspan="1" colspan="1">189 (24.54)</td><td rowspan="2" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">No</td><td align="center" valign="bottom" rowspan="1" colspan="1">3,007 (85.36)</td><td align="center" valign="bottom" rowspan="1" colspan="1">2,409 (87.12)</td><td align="center" valign="bottom" rowspan="1" colspan="1">598 (75.46)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Alcohol user (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Former</td><td align="center" valign="bottom" rowspan="1" colspan="1">308 (8.77)</td><td align="center" valign="bottom" rowspan="1" colspan="1">216 (7.66)</td><td align="center" valign="bottom" rowspan="1" colspan="1">92 (15.08)</td><td rowspan="5" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Never</td><td align="center" valign="bottom" rowspan="1" colspan="1">433 (8.69)</td><td align="center" valign="bottom" rowspan="1" colspan="1">357 (9.08)</td><td align="center" valign="bottom" rowspan="1" colspan="1">76 (6.49)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Mild</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,688 (47.52)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,338 (48.38)</td><td align="center" valign="bottom" rowspan="1" colspan="1">350 (42.69)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Moderate</td><td align="center" valign="bottom" rowspan="1" colspan="1">636 (19.89)</td><td align="center" valign="bottom" rowspan="1" colspan="1">494 (20.01)</td><td align="center" valign="bottom" rowspan="1" colspan="1">142 (19.22)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Heavy</td><td align="center" valign="bottom" rowspan="1" colspan="1">561 (15.12)</td><td align="center" valign="bottom" rowspan="1" colspan="1">434 (14.88)</td><td align="center" valign="bottom" rowspan="1" colspan="1">127 (16.52)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Creatinine (mg/dL)</td><td align="center" valign="bottom" rowspan="1" colspan="1">78.56&#x0202f;&#x000b1;&#x0202f;0.63</td><td align="center" valign="bottom" rowspan="1" colspan="1">77.43&#x0202f;&#x000b1;&#x0202f;0.60</td><td align="center" valign="bottom" rowspan="1" colspan="1">84.94&#x0202f;&#x000b1;&#x0202f;2.00</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">hs-CRP/HDL-C ratio</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.07&#x0202f;&#x000b1;&#x0202f;0.00</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.07&#x0202f;&#x000b1;&#x0202f;0.00</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.13&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">hs-CRP/HDL-C ratio (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Q1</td><td align="center" valign="bottom" rowspan="1" colspan="1">934 (29.73)</td><td align="center" valign="bottom" rowspan="1" colspan="1">810 (32.01)</td><td align="center" valign="bottom" rowspan="1" colspan="1">124 (16.87)</td><td rowspan="4" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Q2</td><td align="center" valign="bottom" rowspan="1" colspan="1">872 (23.31)</td><td align="center" valign="bottom" rowspan="1" colspan="1">706 (24.02)</td><td align="center" valign="bottom" rowspan="1" colspan="1">166 (19.34)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Q3</td><td align="center" valign="bottom" rowspan="1" colspan="1">917 (24.33)</td><td align="center" valign="bottom" rowspan="1" colspan="1">698 (23.77)</td><td align="center" valign="bottom" rowspan="1" colspan="1">219 (27.48)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Q4</td><td align="center" valign="bottom" rowspan="1" colspan="1">903 (22.63)</td><td align="center" valign="bottom" rowspan="1" colspan="1">625 (20.20)</td><td align="center" valign="bottom" rowspan="1" colspan="1">278 (36.32)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Hypertension (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Yes</td><td align="center" valign="bottom" rowspan="1" colspan="1">2073 (50.20)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,435 (44.83)</td><td align="center" valign="bottom" rowspan="1" colspan="1">638 (80.54)</td><td rowspan="2" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">No</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,553 (49.80)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1,404 (55.17)</td><td align="center" valign="bottom" rowspan="1" colspan="1">149 (19.46)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Diabetes mellitus (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">DM</td><td align="center" valign="bottom" rowspan="1" colspan="1">926 (19.44)</td><td align="center" valign="bottom" rowspan="1" colspan="1">550 (14.98)</td><td align="center" valign="bottom" rowspan="1" colspan="1">376 (44.67)</td><td rowspan="3" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Pre-DM</td><td align="center" valign="bottom" rowspan="1" colspan="1">367 (11.14)</td><td align="center" valign="bottom" rowspan="1" colspan="1">315 (11.33)</td><td align="center" valign="bottom" rowspan="1" colspan="1">52 (10.07)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">No</td><td align="center" valign="bottom" rowspan="1" colspan="1">2,333 (69.41)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1974 (73.69)</td><td align="center" valign="bottom" rowspan="1" colspan="1">359 (45.25)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Stroke (<italic>n</italic>, %)</td><td colspan="3" rowspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c; 0.0001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Yes</td><td align="center" valign="bottom" rowspan="1" colspan="1">193 (3.53)</td><td align="center" valign="bottom" rowspan="1" colspan="1">78 (1.90)</td><td align="center" valign="bottom" rowspan="1" colspan="1">115 (12.75)</td><td rowspan="2" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">No</td><td align="center" valign="bottom" rowspan="1" colspan="1">3,433 (96.47)</td><td align="center" valign="bottom" rowspan="1" colspan="1">2,761 (98.10)</td><td align="center" valign="bottom" rowspan="1" colspan="1">672 (87.25)</td></tr></tbody></table><table-wrap-foot><p>hs-CRP, high-sensitivity C-reactive protein; HDL-C, high-density lipoprotein cholesterol; DM, Diabetes mellitus; BMI, body mass index; FITPR, family income-to-poverty ratio. Continuous variables are presented as survey-weighted mean &#x000b1; standard error [SE], and categorical variables are presented as survey-weighted counts and percentages. For continuous variables: <italic>p</italic> values were calculated by survey-weighted t-test. For categorical variables: <italic>p</italic> values were calculated by survey-weighted Chi-square test.</p></table-wrap-foot></table-wrap></sec><sec id="sec14"><label>3.2</label><title>Association between the hs-CRP/HDL-C ratio and frailty status</title><p><xref rid="tab2" ref-type="table">Table 2</xref> illustrates the associations between the quartiles of the hs-CRP/HDL-C ratio and frailty status. After adjusting for all confounding covariates, individuals in the highest quartile of the hs-CRP/HDL-C ratio displayed a significantly higher odds ratio (OR) for frailty compared to those in the lowest quartile (OR&#x0202f;=&#x0202f;1.736, 95% CI: 1.009, 2.988). The multivariable-adjusted RCS analysis revealed a non-linear relationship between the hs-CRP/HDL-C ratio and frailty, observed in the overall population as well as in subgroups of frailty and non-frailty individuals (<italic>P</italic> for nonlinear &#x0003c; 0.05, <xref rid="fig2" ref-type="fig">Figures 2A&#x02013;C</xref>).</p><table-wrap position="float" id="tab2"><label>Table 2</label><caption><p>Correlations between the four quartiles of hs-CRP/HDL-C ratio and frailty status.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" valign="top" colspan="2" rowspan="1">Crude model</th><th align="center" valign="top" colspan="2" rowspan="1">Model I</th><th align="center" valign="top" colspan="2" rowspan="1">Model II</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">Variables</th><th align="center" valign="top" rowspan="1" colspan="1">Crude OR (95%CI)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>-value</th><th align="center" valign="top" rowspan="1" colspan="1">Adjusted OR (95%CI)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>-value</th><th align="center" valign="top" rowspan="1" colspan="1">Adjusted OR (95%CI)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left" valign="middle" colspan="7" rowspan="1">hs-CRP/HDL-C ratio</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Q1 group</td><td align="center" valign="middle" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Q2 group</td><td align="center" valign="bottom" rowspan="1" colspan="1">1.528 (1.035, 2.255)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.034</td><td align="center" valign="bottom" rowspan="1" colspan="1">1.402 (0.947, 2.076)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.089</td><td align="center" valign="bottom" rowspan="1" colspan="1">1.057 (0.709, 1.575)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.769</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Q3 group</td><td align="center" valign="bottom" rowspan="1" colspan="1">2.194 (1.585, 3.036)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" valign="bottom" rowspan="1" colspan="1">2.126 (1.547, 2.921)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" valign="bottom" rowspan="1" colspan="1">1.232 (0.797, 1.905)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.320</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Q4 group</td><td align="center" valign="bottom" rowspan="1" colspan="1">3.411 (2.364, 4.921)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" valign="bottom" rowspan="1" colspan="1">3.391 (2.322, 4.954)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" valign="bottom" rowspan="1" colspan="1">1.736 (1.009, 2.988)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.047</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>P</italic> for trend</td><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.037</td></tr></tbody></table><table-wrap-foot><p>Crude Model: unadjusted.</p><p>Model I: adjusted for age, gender, education status, and ethnicity.</p><p>Model II: adjusted for age, gender, marital status, ethnicity, education status, BMI, energy intake, FITPR, physical activity, smoking status, alcohol user status, creatinine levels, hypertension, diabetes mellitus, and stroke status. Bold values indicate statistically significant results (<italic>p</italic> &#x0003c; 0.05).</p></table-wrap-foot></table-wrap><fig position="float" id="fig2"><label>Figure 2</label><caption><p>RCS for the correlation between the hs-CRP/HDL-C ratio and frailty index. The RCS analysis was performed in the overall population <bold>(A)</bold>, as well as in subgroups specifically categorized as frailty <bold>(B)</bold> or non-frailty <bold>(C)</bold> individuals.</p></caption><graphic xlink:href="fpubh-13-1564206-g002" position="float"/></fig></sec><sec id="sec15"><label>3.3</label><title>Associations between the hs-CRP/HDL-C ratio and plasma proteins</title><p>Plasma proteins, particularly albumin and globulin, have been associated with nutrition and inflammation (<xref rid="ref25" ref-type="bibr">25</xref>). In our study, we employed a multivariate linear regression model to explore the connections between the hs-CRP/HDL-C ratio and these plasma proteins. Notably, as depicted in <xref rid="tab3" ref-type="table">Table 3</xref>, the hs-CRP/HDL-C ratio displayed a significantly negative correlation with albumin (<italic>&#x003b2;</italic>&#x0202f;=&#x0202f;&#x02212;0.011; 95% CI &#x02013;0.013, &#x02013;0.010, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.0001), while showing a positive association with globulin (<italic>&#x003b2;</italic>&#x0202f;=&#x0202f;0.007; 95% CI 0.006, 0.008, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.0001).</p><table-wrap position="float" id="tab3"><label>Table 3</label><caption><p>Multivariate linear regression of hs-CRP/HDL-C ratio with plasma proteins.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">
<italic>n</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic>&#x003b2;</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">95%CI</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left" valign="middle" colspan="5" rowspan="1">hs-CRP/HDL-C ratio</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">albumin (g/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">3,624</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.011</td><td align="center" valign="middle" rowspan="1" colspan="1">(&#x02212;0.013, &#x02212;0.010)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">globulin (g/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">3,624</td><td align="center" valign="middle" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.006, 0.008)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr></tbody></table></table-wrap></sec><sec id="sec16"><label>3.4</label><title>The mediating role of plasma proteins in the association between the hs-CRP/HDL-C ratio and frailty</title><p>As illustrated in <xref rid="fig3" ref-type="fig">Figure 3</xref>, both albumin and globulin displayed significant mediation effects on the association between the hs-CRP/HDL-C ratio and frailty, with mediated proportions of 37.82% (<italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.001, <xref rid="fig3" ref-type="fig">Figure 3A</xref>) and 11.23% (<italic>p</italic>&#x0202f;=&#x0202f;0.016, <xref rid="fig3" ref-type="fig">Figure 3B</xref>), respectively.</p><fig position="float" id="fig3"><label>Figure 3</label><caption><p>Path diagram illustrating the mediating role of plasma proteins. The graphs in <bold>(A,B)</bold> showed the mediating role of albumin and globulin, respectively.</p></caption><graphic xlink:href="fpubh-13-1564206-g003" position="float"/></fig></sec><sec id="sec17"><label>3.5</label><title>LASSO regression and nomogram model</title><p>LASSO regression was employed to identify the relevant factors most associated with frailty. The LASSO regression model selected nine factors with non-zero coefficients in the training dataset, including the hs-CRP/HDL-C ratio, age, BMI, gender, FITPR, smoke, DM status, hypertension status, and stroke status (<xref rid="fig4" ref-type="fig">Figure 4</xref>) in the final model. These nine independent predictors were subsequently included in the nomogram construction (<xref rid="fig5" ref-type="fig">Figure 5</xref>). The ROC analysis demonstrated that the nomogram exhibited strong discriminatory power, with an AUC of 79.7% (95% CI 77.7&#x02013;81.75%) in the training set and an AUC of 78.2% (95% CI 75.0&#x02013;81.4%) in the validation set (<xref rid="fig6" ref-type="fig">Figure 6</xref>).</p><fig position="float" id="fig4"><label>Figure 4</label><caption><p>LASSO regression analysis to identify key variables most correlated with frailty. <bold>(A)</bold> A LASSO regression coefficient plot was constructed. Each curve represents the trajectory of an individual feature coefficient. <bold>(B)</bold> Cross-validation plot.</p></caption><graphic xlink:href="fpubh-13-1564206-g004" position="float"/></fig><fig position="float" id="fig5"><label>Figure 5</label><caption><p>Nomogram for predicting the risk of frailty. The points corresponding to each feature were summed to obtain a total score, and a vertical line was drawn from the total score to determine the &#x02018;frailty risk&#x02019;. The red points illustrate a specific example: for a 67-year-old male participant with DM and hypertension, but a low hs-CRP/HDL-C ratio, the predicted probability of frailty is 34.1%.</p></caption><graphic xlink:href="fpubh-13-1564206-g005" position="float"/></fig><fig position="float" id="fig6"><label>Figure 6</label><caption><p>ROC curves for predicting frailty among middle-aged and older adults, presented for the training dataset <bold>(A)</bold> and the validation dataset <bold>(B)</bold>.</p></caption><graphic xlink:href="fpubh-13-1564206-g006" position="float"/></fig></sec></sec><sec sec-type="discussion" id="sec18"><label>4</label><title>Discussion</title><p>The prevalence of frailty is increasing with the aging population. Frailty, characterized by functional decline and increased risk of adverse outcomes such as falls, hospitalizations, and complications (<xref rid="ref26" ref-type="bibr">26</xref>), arises from multisystem dysregulation and metabolic imbalances (<xref rid="ref4" ref-type="bibr">4</xref>). Its diagnosis remains clinically challenging, and delayed recognition may lead to increased healthcare costs. Systemic inflammation has been linked to frailty risk (<xref rid="ref18" ref-type="bibr">18</xref>). A 3-year longitudinal study in China revealed that hs-CRP contributes to frailty development (<xref rid="ref10" ref-type="bibr">10</xref>). Besides, higher HDL-C levels have been associated with improved well-being and physical health (<xref rid="ref15" ref-type="bibr">15</xref>, <xref rid="ref27" ref-type="bibr">27</xref>). HDL-C, with its roles in reverse cholesterol transport, anti-inflammatory, and antioxidant functions, may exert protective effects against age-related diseases (<xref rid="ref28" ref-type="bibr">28</xref>). The hs-CRP/HDL-C ratio, a composite marker of inflammation and lipid status, reflects the balance between pro- and anti-inflammatory processes. This ratio has been recognized as a clinically relevant biomarker for cardiovascular diseases(CVD), metabolic dysfunction-associated steatotic liver disease (MASLD), advanced liver fibrosis, and poor outcomes in acute ischemic stroke (<xref rid="ref16" ref-type="bibr">16</xref>, <xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref30" ref-type="bibr">30</xref>), due to its simplicity and clinical relevance. These conditions, in turn, are known contributors to frailty. CVD may promote frailty by reducing physical activity and functional capacity (<xref rid="ref31" ref-type="bibr">31</xref>). Similarly, the progression of MASLD is frequently accompanied by sarcopenia, insulin resistance, and chronic inflammation, all of which are implicated in frailty development (<xref rid="ref32" ref-type="bibr">32</xref>). In older stroke patients, diminished multi-organ function and physiological reserve may reduce the ability to respond to external stressors, thereby increasing frailty risk (<xref rid="ref33" ref-type="bibr">33</xref>). Therefore, an elevated hs-CRP/HDL-C ratio may contribute to frailty development through its associations with chronic comorbidities and systemic dysfunction. In our nationally representative U.S. sample, we observed a significant and non-linear association between the hs-CRP/HDL-C ratio and frailty risk among middle-aged and older adults. Collectively, these findings suggest that the hs-CRP/HDL-C holds promise as a potential biomarker for frailty assessment in this population.</p><p>The precise mechanisms underlying the association between the hs-CRP/HDL-C ratio and frailty remain elusive. Albumin, a vital serum protein component, exerts nutritional and antioxidant functions, whereas globulin, an immunoglobulin type, is indicative of systemic inflammatory activity (<xref rid="ref34" ref-type="bibr">34</xref>, <xref rid="ref35" ref-type="bibr">35</xref>). Hypoalbuminemia, which worsens with age, is associated with both malnutrion and inflammation (<xref rid="ref36" ref-type="bibr">36</xref>), and prior studies have identified albumin as a potential biomarker for frailty (<xref rid="ref37" ref-type="bibr">37</xref>, <xref rid="ref38" ref-type="bibr">38</xref>). In our analysis, the hs-CRP/HDL-C ratio was negatively associated with albumin and positively related to globulin. These plasma proteins partially mediated the relationship between the hs-CRP/HDL-C ratio and frailty, suggesting their roles in inflammation-related frailty pathogenesis.</p><p>Identifying critical predictors is essential for the prevention and early management of frailty. In this study, LASSO regression was employed for variable selection. Our analysis identified the hs-CRP/HDL-C ratio, age, BMI, gender, FITPR, smoke, DM status, hypertension status, and stroke status as key predictors of frailty. Frailty, a clinical syndrome characterized by diminished muscle mass and physical activity, is closely linked to aging (<xref rid="ref39" ref-type="bibr">39</xref>). Sex differences also influence frailty risk; men generally have greater muscle mass than women due to higher androgen levels (<xref rid="ref40" ref-type="bibr">40</xref>). Elevated BMI is linked to increased comorbidities, such as diabetes and cardiovascular disease, and has been related to higher frailty risk in older adults (<xref rid="ref41" ref-type="bibr">41</xref>). Beyond physiological factors, social health factors such as poverty is associated with frailty by reflecting cumulative health risks over time (<xref rid="ref42" ref-type="bibr">42</xref>). Besides, tobacco use has been associated with telomere shortening, sarcopenia, reduced gait speed, and physical inactivity, indicating its potential role in age-related frailty (<xref rid="ref43" ref-type="bibr">43</xref>). Hypertension may elevate frailty risk through mechanisms involving polypharmacy, physical and cognitive decline, and fall susceptibility in older adults (<xref rid="ref44" ref-type="bibr">44</xref>). Similarly, DM promotes frailty via dysglycemia, sarcopenia, decreased muscle strength, and multimorbidity (<xref rid="ref45" ref-type="bibr">45</xref>). In older patients, stroke may contribute to frailty through neurological dysfunction, sarcopenia and malnutrition (<xref rid="ref46" ref-type="bibr">46</xref>). Our study supports a positive association between the hs-CRP/HDL-C ratio and frailty. Based on the identified predictors, we constructed a nomogram to serve as a predictive tool for frailty risk. This model may assist clinicians to efficiently identify individuals at high risk of frailty and initiate appropriate interventions in a timely manner.</p><p>Several limitations were identified in our study. First, we did not evaluate the cumulative impact of the hs-CRP/HDL-C ratio on frailty status. Second, the retrospective nature of self-reported data, such as smoking and alcohol use, may lead to recall bias, potentially leading to misclassification. Third, due to the observational design, causal relationships between hs-CRP/HDL-C and frailty cannot be determined. Although we adjusted for a wide range of potential confounders, there may be residual confounding from unmeasured factors that influence the association. While NHANES provides a nationally representative sample, our findings may not be applicable to individuals with specific health conditions-such as rare or severe conditions. Therefore, future study in specific populations is needed to validate our results and improve clinical applicability. Moreover, multiple biomarkers reflecting oxidative stress, nutrition, and aging&#x02014;such as oxidative balance score (OBS), composite dietary antioxidant index (CDAI), albumin, globulin, and klotho&#x02014;have been proposed in relation to frailty (<xref rid="ref4" ref-type="bibr">4</xref>). Previous studies showed that OBS or CDAI has significant associations with frailty (<xref rid="ref47" ref-type="bibr">47</xref>, <xref rid="ref48" ref-type="bibr">48</xref>). Although our primary focus was the hs-CRP/HDL-C ratio, we also evaluated additional markers (e.g., albumin, globulin) and demonstrated their partial mediating roles in the association between hs-CRP/HDL-C ratio and frailty. Nonetheless, some relevant biomarkers were not included in our analysis, limiting our ability to capture the full biological complexity of frailty. Future prospective studies incorporating more comprehensive data, as well as longitudinal or interventional designs, are needed to validate these findings and further explore the underlying mechanisms.</p></sec><sec sec-type="conclusions" id="sec19"><label>5</label><title>Conclusion</title><p>In summary, this cross-sectional study of middle-aged and older participants demonstrated a positive association between frailty and the hs-CRP/HDL-C ratio. Plasma proteins, including albumin and globulin, were identified as mediators in this correlation. Through LASSO regression, the key factors correlated with frailty were identified, and a nomogram was subsequently developed to estimate frailty risk. These findings emphasize the critical role of the hs-CRP/HDL-C ratio in predicting frailty risk, highlighting its potential clinical utility.</p></sec></body><back><ack><p>We would like to thank the NHANES team for providing the data.</p></ack><fn-group><title>Abbreviations</title><fn fn-type="abbr"><p>BMI, Body mass index; CRP, C-reactive protein; hs-CRP, high-sensitivity C-reactive protein; HDL-C, high-density lipoprotein cholesterol; FITPR, family income-to-poverty ratio; NHANES, National Health and Nutrition Examination Survey; OR, Odds ratio; CI, Confidence interval; DM, Diabetes mellitus; IFG, impaired fasting glycaemia; IGT, impaired glucose tolerance.</p></fn></fn-group><sec sec-type="data-availability" id="sec20"><title>Data availability statement</title><p>The datasets presented in this study can be found in online repositories: <ext-link xlink:href="https://wwwn.cdc.gov/nchs/nhanes/" ext-link-type="uri">https://wwwn.cdc.gov/nchs/nhanes/</ext-link>. Further inquiries can be directed to the corresponding author.</p></sec><sec sec-type="ethics-statement" id="sec21"><title>Ethics statement</title><p>Ethical approval for NHANES was obtained from the National Center for Health Statistics (NCHS) Institutional Review Board (Protocol #2011&#x02013;17), and informed consent was obtained from all participants prior to data collection. As this study involved secondary analysis of publicly available data, additional ethical approval was not required. All procedures were conducted in accordance with local legislation and institutional requirements.</p></sec><sec sec-type="author-contributions" id="sec22"><title>Author contributions</title><p>YiW: Funding acquisition, Methodology, Writing &#x02013; review &#x00026; editing. JS: Methodology, Writing &#x02013; review &#x00026; editing. YaW: Conceptualization, Investigation, Methodology, Supervision, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="sec24"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="sec25"><title>Generative AI statement</title><p>The authors declare that no Gen AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="sec26"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec sec-type="supplementary-material" id="sec27"><title>Supplementary material</title><p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fpubh.2025.1564206/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fpubh.2025.1564206/full#supplementary-material</ext-link></p><supplementary-material id="SM1" position="float" content-type="local-data"><media xlink:href="Table_1.docx"/></supplementary-material></sec><ref-list><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ofori-Asenso</surname><given-names>R</given-names></name><name><surname>Chin</surname><given-names>KL</given-names></name><name><surname>Mazidi</surname><given-names>M</given-names></name><name><surname>Zomer</surname><given-names>E</given-names></name><name><surname>Ilomaki</surname><given-names>J</given-names></name><name><surname>Zullo</surname><given-names>AR</given-names></name><etal/></person-group>. <article-title>Global incidence of frailty and prefrailty among community-dwelling older adults: a systematic review and meta-analysis</article-title>. <source>JAMA Netw Open</source>. (<year>2019</year>) <volume>2</volume>:<fpage>e198398</fpage>. doi: <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.8398</pub-id>, PMID: <pub-id pub-id-type="pmid">31373653</pub-id>
</mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Assar</surname><given-names>M</given-names></name><name><surname>Rodr&#x000ed;guez-S&#x000e1;nchez</surname><given-names>I</given-names></name><name><surname>&#x000c1;lvarez-Bustos</surname><given-names>A</given-names></name><name><surname>Rodr&#x000ed;guez-Ma&#x000f1;as</surname><given-names>L</given-names></name></person-group>. <article-title>Biomarkers of frailty</article-title>. <source>Mol Asp Med</source>. (<year>2024</year>) <volume>97</volume>:<fpage>101271</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mam.2024.101271</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenholm</surname><given-names>S</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Vahtera</surname><given-names>J</given-names></name><name><surname>Hoogendijk</surname><given-names>EO</given-names></name><name><surname>Huisman</surname><given-names>M</given-names></name><name><surname>Pentti</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Natural course of frailty components in people who develop frailty syndrome: evidence from two cohort studies</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>. (<year>2019</year>) <volume>74</volume>:<fpage>667</fpage>&#x02013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.1093/gerona/gly132</pub-id>, PMID: <pub-id pub-id-type="pmid">30084927</pub-id>
</mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzi&#x00119;gielewska-G&#x00119;siak</surname><given-names>S</given-names></name><name><surname>Muc-Wierzgo&#x00144;</surname><given-names>M</given-names></name></person-group>. <article-title>Inflammation and oxidative stress in frailty and metabolic syndromes-two sides of the same coin</article-title>. <source>Meta</source>. (<year>2023</year>) <volume>13</volume>:<fpage>475</fpage>. doi: <pub-id pub-id-type="doi">10.3390/metabo13040475</pub-id>, PMID: <pub-id pub-id-type="pmid">37110134</pub-id>
</mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>B</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Association between frailty and chronic constipation and chronic diarrhea among American older adults: National Health and nutrition examination survey</article-title>. <source>BMC Geriatr</source>. (<year>2023</year>) <volume>23</volume>:<fpage>745</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12877-023-04438-4</pub-id>, PMID: <pub-id pub-id-type="pmid">37968629</pub-id>
</mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>MJ</given-names></name><name><surname>Xiong</surname><given-names>YZ</given-names></name><name><surname>Xu</surname><given-names>XJ</given-names></name><name><surname>Huang</surname><given-names>LF</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>XJ</given-names></name><etal/></person-group>. <article-title>Tfh cell subset biomarkers and inflammatory markers are associated with frailty status and frailty subtypes in the community-dwelling older population: a cross-sectional study</article-title>. <source>Aging</source>. (<year>2020</year>) <volume>12</volume>:<fpage>2952</fpage>&#x02013;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.18632/aging.102789</pub-id>, PMID: <pub-id pub-id-type="pmid">32039831</pub-id>
</mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westbrook</surname><given-names>R</given-names></name><name><surname>Chung</surname><given-names>T</given-names></name><name><surname>Lovett</surname><given-names>J</given-names></name><name><surname>Ward</surname><given-names>C</given-names></name><name><surname>Joca</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Kynurenines link chronic inflammation to functional decline and physical frailty</article-title>. <source>JCI Insight</source>. (<year>2020</year>) <volume>5</volume>:e136091. doi: <pub-id pub-id-type="doi">10.1172/jci.insight.136091</pub-id>, PMID: <pub-id pub-id-type="pmid">32814718</pub-id>
</mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuttle</surname><given-names>CSL</given-names></name><name><surname>Thang</surname><given-names>LAN</given-names></name><name><surname>Maier</surname><given-names>AB</given-names></name></person-group>. <article-title>Markers of inflammation and their association with muscle strength and mass: a systematic review and meta-analysis</article-title>. <source>Ageing Res Rev</source>. (<year>2020</year>) <volume>64</volume>:<fpage>101185</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.arr.2020.101185</pub-id>, PMID: <pub-id pub-id-type="pmid">32992047</pub-id>
</mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamil</surname><given-names>RJ</given-names></name><name><surname>Betz</surname><given-names>J</given-names></name><name><surname>Powers</surname><given-names>BB</given-names></name><name><surname>Pratt</surname><given-names>S</given-names></name><name><surname>Kritchevsky</surname><given-names>S</given-names></name><name><surname>Ayonayon</surname><given-names>HN</given-names></name><etal/></person-group>. <article-title>Association of hearing impairment with incident frailty and falls in older adults</article-title>. <source>J Aging Health</source>. (<year>2016</year>) <volume>28</volume>:<fpage>644</fpage>&#x02013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0898264315608730</pub-id>, PMID: <pub-id pub-id-type="pmid">26438083</pub-id>
</mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>YF</given-names></name><name><surname>Cheng</surname><given-names>ZJ</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name><name><surname>Jiang</surname><given-names>XY</given-names></name><name><surname>Lei</surname><given-names>SF</given-names></name><name><surname>Deng</surname><given-names>FY</given-names></name><etal/></person-group>. <article-title>Unraveling the relationship between high-sensitivity C-reactive protein and frailty: evidence from longitudinal cohort study and genetic analysis</article-title>. <source>BMC Geriatr</source>. (<year>2024</year>) <volume>24</volume>:<fpage>222</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12877-024-04836-2</pub-id>, PMID: <pub-id pub-id-type="pmid">38439017</pub-id>
</mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolver</surname><given-names>MG</given-names></name><name><surname>Emanuelsson</surname><given-names>F</given-names></name><name><surname>Nordestgaard</surname><given-names>BG</given-names></name><name><surname>Benn</surname><given-names>M</given-names></name></person-group>. <article-title>Contributions of elevated CRP, hyperglycaemia, and type 2 diabetes to cardiovascular risk in the general population: observational and Mendelian randomization studies</article-title>. <source>Cardiovasc Diabetol</source>. (<year>2024</year>) <volume>23</volume>:<fpage>165</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12933-024-02207-0</pub-id>, PMID: <pub-id pub-id-type="pmid">38730445</pub-id>
</mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>S</given-names></name><name><surname>De Marchis</surname><given-names>GM</given-names></name></person-group>. <article-title>Inflammatory biomarkers and stroke subtype: an important new frontier</article-title>. <source>Neurology</source>. (<year>2024</year>) <volume>102</volume>:<fpage>e208098</fpage>. doi: <pub-id pub-id-type="doi">10.1212/wnl.0000000000208098</pub-id>, PMID: <pub-id pub-id-type="pmid">38165352</pub-id>
</mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milman</surname><given-names>S</given-names></name><name><surname>Atzmon</surname><given-names>G</given-names></name><name><surname>Crandall</surname><given-names>J</given-names></name><name><surname>Barzilai</surname><given-names>N</given-names></name></person-group>. <article-title>Phenotypes and genotypes of high density lipoprotein cholesterol in exceptional longevity</article-title>. <source>Curr Vasc Pharmacol</source>. (<year>2014</year>) <volume>12</volume>:<fpage>690</fpage>&#x02013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1570161111666131219101551</pub-id>, PMID: <pub-id pub-id-type="pmid">24350928</pub-id>
</mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosmas</surname><given-names>CE</given-names></name><name><surname>Sourlas</surname><given-names>A</given-names></name><name><surname>Guzman</surname><given-names>E</given-names></name><name><surname>Kostara</surname><given-names>CE</given-names></name></person-group>. <article-title>Environmental factors modifying HDL functionality</article-title>. <source>Curr Med Chem</source>. (<year>2022</year>) <volume>29</volume>:<fpage>1687</fpage>&#x02013;<lpage>701</lpage>. doi: <pub-id pub-id-type="doi">10.2174/0929867328666210714155422</pub-id><pub-id pub-id-type="pmid">34269662</pub-id>
</mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>The identification and prediction of frailty based on Bayesian network analysis in a community-dwelling older population</article-title>. <source>BMC Geriatr</source>. (<year>2022</year>) <volume>22</volume>:<fpage>847</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12877-022-03520-7</pub-id>, PMID: <pub-id pub-id-type="pmid">36368951</pub-id>
</mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>The predictive value of the hs-CRP/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people: evidence from a large national cohort study</article-title>. <source>Lipids Health Dis</source>. (<year>2024</year>) <volume>23</volume>:<fpage>66</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12944-024-02055-7</pub-id>, PMID: <pub-id pub-id-type="pmid">38429790</pub-id>
</mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakeem</surname><given-names>FF</given-names></name><name><surname>Bernab&#x000e9;</surname><given-names>E</given-names></name><name><surname>Sabbah</surname><given-names>W</given-names></name></person-group>. <article-title>Association between oral health and frailty among American older adults</article-title>. <source>J Am Med Dir Assoc</source>. (<year>2021</year>) <volume>22</volume>:<fpage>559</fpage>&#x02013;<lpage>563.e2</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jamda.2020.07.023</pub-id>, PMID: <pub-id pub-id-type="pmid">32859517</pub-id>
</mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name></person-group>. <article-title>Association of two novel systemic inflammatory biomarkers and frailty based on NHANES 2007-2018</article-title>. <source>Front Public Health</source>. (<year>2024</year>) <volume>12</volume>:<fpage>1377408</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2024.1377408</pub-id>, PMID: <pub-id pub-id-type="pmid">38655524</pub-id>
</mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Bian</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Frailty index and all-cause and cause-specific mortality in Chinese adults: a prospective cohort study</article-title>. <source>Lancet Public Health</source>. (<year>2020</year>) <volume>5</volume>:<fpage>e650</fpage>&#x02013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s2468-2667(20)30113-4</pub-id>, PMID: <pub-id pub-id-type="pmid">33271078</pub-id>
</mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>Z</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name></person-group>. <article-title>Association between serum klotho and physical frailty in middle-aged and older adults: finding from the National Health and nutrition examination survey</article-title>. <source>J Am Med Dir Assoc</source>. (<year>2023</year>) <volume>24</volume>:<fpage>1173</fpage>&#x02013;<lpage>1178.e2</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jamda.2023.02.103</pub-id>, PMID: <pub-id pub-id-type="pmid">37001558</pub-id>
</mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Simonsen</surname><given-names>DW</given-names></name><name><surname>Lehmler</surname><given-names>HJ</given-names></name></person-group>. <article-title>Association between exposure to pyrethroid insecticides and risk of all-cause and cause-specific mortality in the general US adult population</article-title>. <source>JAMA Intern Med</source>. (<year>2020</year>) <volume>180</volume>:<fpage>367</fpage>&#x02013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamainternmed.2019.6019</pub-id>, PMID: <pub-id pub-id-type="pmid">31886824</pub-id>
</mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hupin</surname><given-names>D</given-names></name><name><surname>Roche</surname><given-names>F</given-names></name><name><surname>Gremeaux</surname><given-names>V</given-names></name><name><surname>Chatard</surname><given-names>JC</given-names></name><name><surname>Oriol</surname><given-names>M</given-names></name><name><surname>Gaspoz</surname><given-names>JM</given-names></name><etal/></person-group>. <article-title>Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged &#x02265;60 years: a systematic review and meta-analysis</article-title>. <source>Br J Sports Med</source>. (<year>2015</year>) <volume>49</volume>:<fpage>1262</fpage>&#x02013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1136/bjsports-2014-094306</pub-id>, PMID: <pub-id pub-id-type="pmid">26238869</pub-id>
</mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Rong</surname><given-names>S</given-names></name><name><surname>Dai</surname><given-names>SY</given-names></name><name><surname>Trasande</surname><given-names>L</given-names></name><name><surname>Lehmler</surname><given-names>HJ</given-names></name></person-group>. <article-title>Association between bisphenol a exposure and risk of all-cause and cause-specific mortality in US adults</article-title>. <source>JAMA Netw Open</source>. (<year>2020</year>) <volume>3</volume>:<fpage>e2011620</fpage>. doi: <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.11620</pub-id>, PMID: <pub-id pub-id-type="pmid">32804211</pub-id>
</mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rattan</surname><given-names>P</given-names></name><name><surname>Penrice</surname><given-names>DD</given-names></name><name><surname>Ahn</surname><given-names>JC</given-names></name><name><surname>Ferrer</surname><given-names>A</given-names></name><name><surname>Patnaik</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>VH</given-names></name><etal/></person-group>. <article-title>Inverse association of telomere length with liver disease and mortality in the US population</article-title>. <source>Hepatol Commun</source>. (<year>2022</year>) <volume>6</volume>:<fpage>399</fpage>&#x02013;<lpage>410</lpage>. doi: <pub-id pub-id-type="doi">10.1002/hep4.1803</pub-id>, PMID: <pub-id pub-id-type="pmid">34558851</pub-id>
</mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name></person-group>. <article-title>Associations between albumin, globulin, albumin to globulin ratio and muscle mass in adults: results from the national health and nutrition examination survey 2011-2014</article-title>. <source>BMC Geriatr</source>. (<year>2022</year>) <volume>22</volume>:<fpage>383</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12877-022-03094-4</pub-id>, PMID: <pub-id pub-id-type="pmid">35501822</pub-id>
</mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dent</surname><given-names>E</given-names></name><name><surname>Martin</surname><given-names>FC</given-names></name><name><surname>Bergman</surname><given-names>H</given-names></name><name><surname>Woo</surname><given-names>J</given-names></name><name><surname>Romero-Ortuno</surname><given-names>R</given-names></name><name><surname>Walston</surname><given-names>JD</given-names></name></person-group>. <article-title>Management of frailty: opportunities, challenges, and future directions</article-title>. <source>Lancet (London, England)</source>. (<year>2019</year>) <volume>394</volume>:<fpage>1376</fpage>&#x02013;<lpage>86</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0140-6736(19)31785-4</pub-id>, PMID: <pub-id pub-id-type="pmid">31609229</pub-id>
</mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>W</given-names></name><name><surname>Cao</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Higher normal levels of triglyceride and low and high-density lipoprotein cholesterol might have a protective effect against activities of daily living disability within Chinese female centenarians: a cross-sectional, complete sample study</article-title>. <source>Clin Interv Aging</source>. (<year>2020</year>) <volume>15</volume>:<fpage>225</fpage>&#x02013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.2147/cia.S237505</pub-id>, PMID: <pub-id pub-id-type="pmid">32110002</pub-id>
</mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asztalos</surname><given-names>BF</given-names></name><name><surname>Tani</surname><given-names>M</given-names></name><name><surname>Schaefer</surname><given-names>EJ</given-names></name></person-group>. <article-title>Metabolic and functional relevance of HDL subspecies</article-title>. <source>Curr Opin Lipidol</source>. (<year>2011</year>) <volume>22</volume>:<fpage>176</fpage>&#x02013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MOL.0b013e3283468061</pub-id><pub-id pub-id-type="pmid">21537175</pub-id>
</mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>B</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017-2018</article-title>. <source>Sci Rep</source>. (<year>2025</year>) <volume>15</volume>:<fpage>4029</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-025-88685-y</pub-id>, PMID: <pub-id pub-id-type="pmid">39900651</pub-id>
</mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luwen</surname><given-names>H</given-names></name><name><surname>Lei</surname><given-names>X</given-names></name><name><surname>Qing-Rong</surname><given-names>O</given-names></name><name><surname>Linlin</surname><given-names>L</given-names></name><name><surname>Ming</surname><given-names>Y</given-names></name></person-group>. <article-title>Association between hs-CRP/HDL-C ratio and three-month unfavorable outcomes in patients with acute ischemic stroke: a second analysis based on a prospective cohort study</article-title>. <source>BMC Neurol</source>. (<year>2024</year>) <volume>24</volume>:<fpage>418</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12883-024-03929-0</pub-id>, PMID: <pub-id pub-id-type="pmid">39468509</pub-id>
</mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takefuji</surname><given-names>Y</given-names></name></person-group>. <article-title>Exploring the connection between frailty and cardiovascular diseases</article-title>. <source>Arch Gerontol Geriatr</source>. (<year>2024</year>) <volume>124</volume>:<fpage>105449</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.archger.2024.105449</pub-id>, PMID: <pub-id pub-id-type="pmid">38669728</pub-id>
</mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karakousis</surname><given-names>ND</given-names></name><name><surname>Chrysavgis</surname><given-names>L</given-names></name><name><surname>Chatzigeorgiou</surname><given-names>A</given-names></name><name><surname>Papatheodoridis</surname><given-names>G</given-names></name><name><surname>Cholongitas</surname><given-names>E</given-names></name></person-group>. <article-title>Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease</article-title>. <source>Ann Gastroenterol</source>. (<year>2022</year>) <volume>35</volume>:<fpage>234</fpage>&#x02013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.20524/aog.2022.0705</pub-id>, PMID: <pub-id pub-id-type="pmid">35599934</pub-id>
</mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YN</given-names></name><name><surname>Yan</surname><given-names>FH</given-names></name><name><surname>Wang</surname><given-names>XY</given-names></name><name><surname>Chen</surname><given-names>XL</given-names></name><name><surname>Chong</surname><given-names>HY</given-names></name><name><surname>Su</surname><given-names>WL</given-names></name><etal/></person-group>. <article-title>Prevalence and risk factors of frailty in stroke patients: a meta-analysis and systematic review</article-title>. <source>J Nutr Health Aging</source>. (<year>2023</year>) <volume>27</volume>:<fpage>96</fpage>&#x02013;<lpage>102</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12603-023-1879-z</pub-id>, PMID: <pub-id pub-id-type="pmid">36806864</pub-id>
</mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>KJ</given-names></name><name><surname>Hsieh</surname><given-names>YP</given-names></name><name><surname>Chiu</surname><given-names>PF</given-names></name><name><surname>Lin</surname><given-names>PR</given-names></name></person-group>. <article-title>Association of albumin and globulin with mortality risk in incident peritoneal dialysis patients</article-title>. <source>Nutrients</source>. (<year>2022</year>) <volume>14</volume>:<fpage>2850</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu14142850</pub-id>, PMID: <pub-id pub-id-type="pmid">35889807</pub-id>
</mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>CY</given-names></name><name><surname>Liou</surname><given-names>SY</given-names></name><name><surname>Kuo</surname><given-names>WW</given-names></name><name><surname>Wu</surname><given-names>HC</given-names></name><name><surname>Chang</surname><given-names>YL</given-names></name><name><surname>Chen</surname><given-names>TS</given-names></name></person-group>. <article-title>Chemiluminescence analysis of antioxidant capacity for serum albumin isolated from healthy or uremic volunteers</article-title>. <source>Luminescence</source>. (<year>2016</year>) <volume>31</volume>:<fpage>1474</fpage>&#x02013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1002/bio.3132</pub-id>, PMID: <pub-id pub-id-type="pmid">27062681</pub-id>
</mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>Yin</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name></person-group>. <article-title>Association between frailty and hypoproteinaemia in older patients: meta-analysis and systematic review</article-title>. <source>BMC Geriatr</source>. (<year>2024</year>) <volume>24</volume>:<fpage>689</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12877-024-05275-9</pub-id>, PMID: <pub-id pub-id-type="pmid">39154175</pub-id>
</mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mailliez</surname><given-names>A</given-names></name><name><surname>Guilbaud</surname><given-names>A</given-names></name><name><surname>Puisieux</surname><given-names>F</given-names></name><name><surname>Dauchet</surname><given-names>L</given-names></name><name><surname>Boulanger</surname><given-names>&#x000c9;</given-names></name></person-group>. <article-title>Circulating biomarkers characterizing physical frailty: CRP, hemoglobin, albumin, 25OHD and free testosterone as best biomarkers. Results of a meta-analysis</article-title>. <source>Exp Gerontol</source>. (<year>2020</year>) <volume>139</volume>:<fpage>111014</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.exger.2020.111014</pub-id>, PMID: <pub-id pub-id-type="pmid">32599147</pub-id>
</mixed-citation></ref><ref id="ref38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Adachi</surname><given-names>H</given-names></name><name><surname>Enomoto</surname><given-names>M</given-names></name><name><surname>Fukami</surname><given-names>A</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Nohara</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Lower albumin levels are associated with frailty measures, trace elements, and an inflammation marker in a cross-sectional study in Tanushimaru</article-title>. <source>Environ Health Prev Med</source>. (<year>2021</year>) <volume>26</volume>:<fpage>25</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12199-021-00946-0</pub-id>, PMID: <pub-id pub-id-type="pmid">33607942</pub-id>
</mixed-citation></ref><ref id="ref39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz-Jentoft</surname><given-names>AJ</given-names></name><name><surname>Baeyens</surname><given-names>JP</given-names></name><name><surname>Bauer</surname><given-names>JM</given-names></name><name><surname>Boirie</surname><given-names>Y</given-names></name><name><surname>Cederholm</surname><given-names>T</given-names></name><name><surname>Landi</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people</article-title>. <source>Age Ageing</source>. (<year>2010</year>) <volume>39</volume>:<fpage>412</fpage>&#x02013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ageing/afq034</pub-id>, PMID: <pub-id pub-id-type="pmid">20392703</pub-id>
</mixed-citation></ref><ref id="ref40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conforto</surname><given-names>R</given-names></name><name><surname>Rizzo</surname><given-names>V</given-names></name><name><surname>Russo</surname><given-names>R</given-names></name><name><surname>Mazza</surname><given-names>E</given-names></name><name><surname>Maurotti</surname><given-names>S</given-names></name><name><surname>Pujia</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Advances in body composition and gender differences in susceptibility to frailty syndrome: role of osteosarcopenic obesity</article-title>. <source>Metab Clin Exp</source>. (<year>2024</year>) <volume>161</volume>:<fpage>156052</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.metabol.2024.156052</pub-id>, PMID: <pub-id pub-id-type="pmid">39490438</pub-id>
</mixed-citation></ref><ref id="ref41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>F</given-names></name></person-group>. <article-title>Longitudinal association between body mass index (BMI), BMI trajectories and the risk of frailty among older adults: a systematic review and meta-analysis of prospective cohort studies</article-title>. <source>Arch Gerontol Geriatr</source>. (<year>2024</year>) <volume>124</volume>:<fpage>105467</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.archger.2024.105467</pub-id>, PMID: <pub-id pub-id-type="pmid">38728821</pub-id>
</mixed-citation></ref><ref id="ref42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolz</surname><given-names>E</given-names></name><name><surname>Mayerl</surname><given-names>H</given-names></name><name><surname>Waxenegger</surname><given-names>A</given-names></name><name><surname>Freidl</surname><given-names>W</given-names></name></person-group>. <article-title>Explaining the impact of poverty on old-age frailty in Europe: material, psychosocial and behavioural factors</article-title>. <source>Eur J Pub Health</source>. (<year>2017</year>) <volume>27</volume>:<fpage>1003</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1093/eurpub/ckx079</pub-id>, PMID: <pub-id pub-id-type="pmid">29020312</pub-id>
</mixed-citation></ref><ref id="ref43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>SG</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Causal linkage of tobacco smoking with ageing: Mendelian randomization analysis towards telomere attrition and sarcopenia</article-title>. <source>J Cachexia Sarcopenia Muscle</source>. (<year>2023</year>) <volume>14</volume>:<fpage>955</fpage>&#x02013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jcsm.13174</pub-id>, PMID: <pub-id pub-id-type="pmid">36696951</pub-id>
</mixed-citation></ref><ref id="ref44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Meng</surname><given-names>L</given-names></name><name><surname>Duan</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Interaction between hypertension and frailty and their impact on death risk in older adults: a follow-up study</article-title>. <source>BMC Geriatr</source>. (<year>2024</year>) <volume>24</volume>:<fpage>187</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12877-024-04793-w</pub-id>, PMID: <pub-id pub-id-type="pmid">38402390</pub-id>
</mixed-citation></ref><ref id="ref45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>CY</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Chao</surname><given-names>CT</given-names></name><name><surname>Hung</surname><given-names>KY</given-names></name><name><surname>Chien</surname><given-names>KL</given-names></name></person-group>. <article-title>The impact of glucose-lowering strategy on the risk of increasing frailty severity among 49,519 patients with diabetes mellitus: a longitudinal cohort study</article-title>. <source>Aging Dis</source>. (<year>2023</year>) <volume>14</volume>:<fpage>1917</fpage>&#x02013;<lpage>26</lpage>. doi: <pub-id pub-id-type="doi">10.14336/ad.2023.0225</pub-id>, PMID: <pub-id pub-id-type="pmid">37196125</pub-id>
</mixed-citation></ref><ref id="ref46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name></person-group>. <article-title>Stroke and frailty index: a two-sample Mendelian randomisation study</article-title>. <source>Aging Clin Exp Res</source>. (<year>2024</year>) <volume>36</volume>:<fpage>114</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s40520-024-02777-9</pub-id>, PMID: <pub-id pub-id-type="pmid">38775917</pub-id>
</mixed-citation></ref><ref id="ref47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>The association between oxidative balance score and frailty in adults across a wide age spectrum: NHANES 2007-2018</article-title>. <source>Food Funct</source>. (<year>2024</year>) <volume>15</volume>:<fpage>5041</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1039/d4fo00870g</pub-id>, PMID: <pub-id pub-id-type="pmid">38651948</pub-id>
</mixed-citation></ref><ref id="ref48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Lei</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name></person-group>. <article-title>The association between the composite dietary antioxidant index and frailty symptoms: mediating effects of oxidative stress</article-title>. <source>Clin Interv Aging</source>. (<year>2024</year>) <volume>19</volume>:<fpage>163</fpage>&#x02013;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.2147/cia.S448354</pub-id>, PMID: <pub-id pub-id-type="pmid">38332967</pub-id>
</mixed-citation></ref></ref-list></back></article>